NM_000059.4:c.1865C>T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 2P and 10B. PM2BP4_ModerateBP6_Very_Strong

The NM_000059.4(BRCA2):​c.1865C>T​(p.Ala622Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000249 in 1,607,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A622E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

BRCA2
NM_000059.4 missense

Scores

2
13

Clinical Significance

Benign reviewed by expert panel U:2B:8

Conservation

PhyloP100: 0.136

Publications

9 publications found
Variant links:
Genes affected
BRCA2 (HGNC:1101): (BRCA2 DNA repair associated) Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020]
BRCA2 Gene-Disease associations (from GenCC):
  • BRCA2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia complementation group D1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • pancreatic cancer, susceptibility to, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.15919974).
BP6
Variant 13-32333343-C-T is Benign according to our data. Variant chr13-32333343-C-T is described in ClinVar as Benign. ClinVar VariationId is 37767.Status of the report is reviewed_by_expert_panel, 3 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000059.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
NM_000059.4
MANE Select
c.1865C>Tp.Ala622Val
missense
Exon 10 of 27NP_000050.3A0A7P0T9D7
BRCA2
NM_001432077.1
c.1865C>Tp.Ala622Val
missense
Exon 10 of 27NP_001419006.1A0A7P0T9D7
BRCA2
NM_001406720.1
c.1865C>Tp.Ala622Val
missense
Exon 10 of 27NP_001393649.1A0A8V8TPZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
ENST00000380152.8
TSL:5 MANE Select
c.1865C>Tp.Ala622Val
missense
Exon 10 of 27ENSP00000369497.3P51587
BRCA2
ENST00000544455.6
TSL:1
c.1865C>Tp.Ala622Val
missense
Exon 10 of 27ENSP00000439902.1P51587
BRCA2
ENST00000530893.7
TSL:1
c.1496C>Tp.Ala499Val
missense
Exon 10 of 27ENSP00000499438.2A0A590UJI7

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151272
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000295
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000833
AC:
2
AN:
240116
AF XY:
0.00000766
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000185
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1456150
Hom.:
0
Cov.:
35
AF XY:
0.00000138
AC XY:
1
AN XY:
723938
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33066
American (AMR)
AF:
0.00
AC:
0
AN:
43814
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25982
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39660
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84278
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52684
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5738
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1110748
Other (OTH)
AF:
0.00
AC:
0
AN:
60180
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
151272
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
73816
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41260
American (AMR)
AF:
0.00
AC:
0
AN:
15194
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10156
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000295
AC:
2
AN:
67892
Other (OTH)
AF:
0.00
AC:
0
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000202
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000165
AC:
2

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
3
Breast-ovarian cancer, familial, susceptibility to, 2 (4)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
1
1
not specified (2)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
Pancreatic cancer, susceptibility to, 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.099
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
19
DANN
Uncertain
0.98
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.35
FATHMM_MKL
Benign
0.12
N
M_CAP
Uncertain
0.090
D
MetaRNN
Benign
0.16
T
MetaSVM
Benign
-0.93
T
PhyloP100
0.14
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.73
N
REVEL
Benign
0.16
Sift
Benign
0.085
T
Sift4G
Benign
0.21
T
Vest4
0.36
MutPred
0.24
Loss of disorder (P = 0.0503)
MVP
0.83
MPC
0.067
ClinPred
0.14
T
GERP RS
2.8
gMVP
0.20
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80358477; hg19: chr13-32907480; API